4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-24-000217
Director sold 1,020 shares at $30.00 ($30,600)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
SATO VICKI L · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-11-07 | Sale : show line 1 in the form 10b5-1 | −1,020 | $30.00 | $30,600 | 111,056 | D |
| Open-market sales · 1,020 sh · avg $30.00 · $30,600 | ||||||
Loading xslF345X05/wk-form4_1731447801.xml…